References
- Kim BE, Leung DYM. Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol Res. 2018;10(3):207–215. doi:10.4168/aair.2018.10.3.207
- Luger T, Amagai M, Dreno B, et al. Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci. 2021;102(3):142–157. doi:10.1016/j.jdermsci.2021.04.007
- Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA. Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(3 Suppl 1):S28–S36. doi:10.1016/j.jaad.2017.12.022
- Rodrigues MA, Torres T. JAK/STAT inhibitors for the treatment of atopic dermatitis. J Dermatolog Treat. 2020;31(1):33–40. doi:10.1080/09546634.2019.1577549
- Cotter DG, Schairer D, Eichenfield L. Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2018;78(3 Suppl 1):S53–S62. doi:10.1016/j.jaad.2017.12.019
- Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314–2324. doi:10.1056/NEJMcp042803
- Tene K, Kalyan Kumar M, Basveshwar G, et al. Polyphenolic-rich compounds from dillenia pentagyna (Roxb.) attenuates the doxorubicin-induced cardiotoxicity: a high-frequency ultrasonography assisted approach. Front Pharmacol. 2021;12:624706. doi:10.3389/fphar.2021.624706
- Sliwinska S, Jeziorek M. The role of nutrition in Alzheimer’s disease. Rocz Panstw Zakl Hig. 2021;72(1):29–39.
- Bhat PB, Hegde S, Upadhya V, Hegde GR, Habbu PV, Mulgund GS. Evaluation of wound healing property of Caesalpinia mimosoides lam. J Ethnopharmacol. 2016;193:712–724. doi:10.1016/j.jep.2016.10.009
- Chao J, Cheng HY, Chang ML, et al. Gallic acid ameliorated impaired lipid homeostasis in a mouse model of high-fat diet-and streptozotocin-induced NAFLD and diabetes through improvement of beta-oxidation and ketogenesis. Front Pharmacol. 2020;11:606759. doi:10.3389/fphar.2020.606759
- Tsang MS, Jiao D, Chan BC, et al. Anti-inflammatory activities of pentaherbs formula, berberine, gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation. Molecules. 2016;21(4):519. doi:10.3390/molecules21040519
- Fan Y, Piao CH, Hyeon E, et al. Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis. Int Immunopharmacol. 2019;70:512–519. doi:10.1016/j.intimp.2019.02.025
- Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, Park MC. Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine. 2013;80(3):274–279. doi:10.1016/j.jbspin.2012.08.010
- Choi EJ, Debnath T, Tang Y, Ryu YB, Moon SH, Kim EK. Topical application of Moringa oleifera leaf extract ameliorates experimentally induced atopic dermatitis by the regulation of Th1/Th2/Th17 balance. Biomed Pharmacother. 2016;84:870–877. doi:10.1016/j.biopha.2016.09.085
- Bai XY, Liu P, Chai YW, et al. Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice. Eur J Pharmacol. 2020;874:173020. doi:10.1016/j.ejphar.2020.173020
- Fu X, Hong C. Osthole attenuates mouse atopic dermatitis by inhibiting thymic stromal lymphopoietin production from keratinocytes. Exp Dermatol. 2019;28(5):561–567. doi:10.1111/exd.13910
- Goindi S, Kumar G, Kumar N, Kaur A. Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. AAPS PharmSciTech. 2013;14(4):1284–1293. doi:10.1208/s12249-013-0017-3
- Singh AK, Khare P, Obaid A, et al. SUMOylation of ROR-gammat inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9(1):4515. doi:10.1038/s41467-018-06924-5
- Shi D, Yang J, Wang Q, et al. SOCS3 ablation enhances DC-derived Th17 immune response against Candida albicans by activating IL-6/STAT3 in vitro. Life Sci. 2019;222:183–194. doi:10.1016/j.lfs.2019.03.009
- Tanaka N, Koido M, Suzuki A, et al. Eight novel susceptibility loci and putative causal variants in atopic dermatitis. J Allergy Clin Immunol. 2021. doi:10.1016/j.jaci.2021.04.019
- Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. J Invest Dermatol. 2009;129(1):31–40. doi:10.1038/jid.2008.106
- Kee HJ, Cho SN, Kim GR, et al. Gallic acid inhibits vascular calcification through the blockade of BMP2-Smad1/5/8 signaling pathway. Vascul Pharmacol. 2014;63(2):71–78. doi:10.1016/j.vph.2014.08.005
- Ryu Y, Jin L, Kee HJ, et al. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Sci Rep. 2016;6:34790. doi:10.1038/srep34790
- Hussein RM, Anwar MM, Farghaly HS, Kandeil MA. Gallic acid and ferulic acid protect the liver from thioacetamide-induced fibrosis in rats via differential expression of miR-21, miR-30 and miR-200 and impact on TGF-beta1/Smad3 signaling. Chem Biol Interact. 2020;324:109098. doi:10.1016/j.cbi.2020.109098
- Jang YG, Ko EB, Choi KC. Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. J Nutr Biochem. 2020;84:108444. doi:10.1016/j.jnutbio.2020.108444
- Medeiros NI, Mattos RT, Menezes CA, et al. IL-10 and TGF-beta unbalanced levels in neutrophils contribute to increase inflammatory cytokine expression in childhood obesity. Eur J Nutr. 2018;57(7):2421–2430. doi:10.1007/s00394-017-1515-y
- Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2002;129(4):263–276. doi:10.1159/000067596
- Dubin C, Del Duca E, Guttman-Yassky E. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Rev Clin Immunol. 2021;17(8):835–852. doi:10.1080/1744666X.2021.1940962